What You Should Know:
- Johnson & Johnson Innovation announces three strategic
collaborations with a focus on advancing healthcare solutions in China.
- The three strategic collaborations are focused on leveraging advances in science and technology to address areas of high unmet medical need across several areas, including discovery science, lung cancer, and medical devices
Johnson & Johnson Innovation, a division of Johnson & Johnson (China) Investment Limited, today
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Aptar Pharma Acquires the Assets of Respiratory Startup Cohero Health
What You Should Know:
- Apstar Pharma acquires the assets of respiratory health company Cohero Health to expands its digital portfolio with a focus on respiratory disease management.
- Cohero Health develops digital tools and technologies to improve respiratory care, reduce avoidable costs, and optimize medication utilization.
AptarGroup, Inc., a global leader in consumer dispensing, active packaging, drug delivery solutions, and services, announces that it has acquired all operating
Read More
How RPA Can Help Get COVID-19 Vaccines to High-Risk Patients First
While most of the public’s attention is focused on the horse race for an approved COVID-19 vaccine, another major hurdle lies just around the corner: the distribution of hundreds of millions of vaccine doses. In today’s highly complex and disconnected health data landscape, technologies like AI, Machine Learning, and robotic process automation (RPA) will be essential to making sure that the highest-risk patients receive the vaccine first.
Why identifying at-risk patients is
Read More
FDA Extends RCA With COTA to Explore COVID’s Effect on Cancer
What You Should Know:
- The FDA just extended its research collaboration
agreement (RCA) with COTA, specifically looking at how COVID-19 is affecting
cancer.
- With this expanded agreement, COTA and the FDA will use real-world data to explore the impact of COVID-19 and the pandemic on cancer treatment, with the opportunity to expand into other oncology questions in the future.
COTA, Inc., a healthcare technology
company that uses real-world data to bring clarity to cancer care,
Read More
MIT’s Algorithm Reduces Unnecessary Use of Antibiotics for UTIs
What You Should Know:
- MIT research team created a machine learning algorithm
that predicts the probability that a patient’s Urinary Tract Infection (UTI)
can be treated by various antibiotics.
- The team showed that the algorithm would allow
clinicians to reduce the use of second-line antibiotics (which have been shown
to put women at risk for potentially dangerous complications) by 67 percent.
For patients where clinicians chose a second-line drug but the algorithm chose
a first-line
Read More
How Data-Driven Technology Holds The Promise of Better Outcomes for Vascular Patients
Abbott recently released global research on vascular patient care, designed to shine a light on the vascular patient journey. The report called “Beyond Intervention” uncovers the universal challenges faced by physicians who deliver vascular care, their patients, and the hospital administrators who support them. It also explores how the right use of technology and data could potentially enable more precise diagnoses and better treatment strategies to ensure the best possible patient
Read More
AI Leads Way to Less False Positives on Remote Cardiac Monitoring Devices, Improved Results
What You Should Know:
- Cardiac patients and their cardiologists are
experiencing a high number of false positives with remote patient monitoring
devices as a result of signal artifact providing inaccurate data, which can
lead to many complications—other than medical, such as unnecessary tests and
increased medical costs.
- Ambulatory cardiac monitoring provider InfoBionic has devised a way to decrease false positives and increase efficiency.
Remote cardiac monitoring’s false
Read More
Will Nanox Disrupt The X-Ray Systems Market?
With its share price falling from more than $66 to less than $24, September was a tumultuous month for Nanox.
On August 25th, the medical imaging start-up closed its initial public offering, having raised $190m from the sale of 10,555,556 ordinary shares at a price of $18 each. Money poured in as investors were sold on Nanox’s cold cathode x-ray source and the subsequent reduction in costs that it would enable, as well as the vendor’s pay-per-scan pricing model that would let the company
Read More
Ontrak Acquires Science-Backed, Behavior Change Platform LifeDojo
What You Should Know:
- Ontrak acquires LifeDojo Inc, a San Francisco, CA-based
comprehensive, science-backed behavior change platform.
- The acquisition broadens Ontrak’s addressable market
and footprint to lower acuity populations enabling new interventions and remote
patient monitoring.
Ontrak, Inc., a
leading AI-powered
and telehealth-enabled,
virtualized healthcare company, today announced that it has acquired
LifeDojo Inc, a comprehensive, science-backed behavior change
Read More
Mayo Clinic Launches Vocal Biomarker Study for Pulmonary Hypertension Detection
What You Should Know:
- Mayo Clinic announced a collaboration with Vocalis
Health to to research and develop new voice-based tools for screening, detecting
and monitoring patient health, beginning with a study to identify vocal
biomarkers to detect pulmonary hypertension (PH).
- The clinical validation study will utilize Vocalis
Health’s proprietary software, which can operate on any connected voice
platform (mobile, computer, tablet, etc.) to analyze patients’ health based on
voice
Read More
